Breaking News

CMAB Biopharma Resumes Full-Scale Operation

Suzhou, China site up and running following the coronavirus outbreak

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CMAB Biopharma has reported that its facility in Suzhou, China has now resumed full operation following the coronavirus COVID-19 outbreak.   On January 21, 2020, CMAB set up a pandemic prevention and control committee led by chief executive officer, Dr. Yongzhong Wang. The committee deployed various pandemic prevention and control measures in advance, led by Environment, Health and Safety (EHS), Public Relations (PR), Human Resources (HR), Procurement, Supply Chain Management (SCM) and IT depart...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters